Not available
Quote | argenx SE (NASDAQ:ARGX)
Last: | $430.04 |
---|---|
Change Percent: | 2.75% |
Open: | $432.69 |
Close: | $430.04 |
High: | $439.12 |
Low: | $428.76 |
Volume: | 515,206 |
Last Trade Date Time: | 06/28/2024 03:00:00 am |
News | argenx SE (NASDAQ:ARGX)
2024-06-28 10:20:00 ET Summary Argenx's shares rose after FDA approval of Vyvgart for the treatment of CIDP. The approval expands the addressable market for Vyvgart, and the company will initially target 12,000 patients in the U.S. who are currently not well controlled on other dr...
2024-06-26 07:00:04 ET Douglas Tsao from H.C. Wainwright issued a price target of $490.00 for ARGX on 2024-06-26 06:09:00. The adjusted price target was set to $490.00. At the time of the announcement, ARGX was trading at $451.55. The overall price target consensus is at...
Message Board Posts | argenx SE (NASDAQ:ARGX)
Subject | By | Source | When |
---|---|---|---|
Looking good | Fred Kadiddlehopper | investorshub | 02/24/2021 2:20:34 PM |
Progress in Sub-cu Efgartigimod was discussed in some | Fred Kadiddlehopper | investorshub | 02/24/2021 2:19:32 PM |
3 Penny Stocks To Buy Or Sell Before | jonny_red | investorshub | 11/05/2019 8:13:01 PM |
* * $AGRX Video Chart 11-01-18 * * | ClayTrader | investorshub | 11/01/2018 9:46:41 PM |
Efgartigimod is a first-in-class antibody fragment designed for | riche | investorshub | 10/17/2018 8:09:07 AM |
News, Short Squeeze, Breakout and More Instantly...
argenx SE Company Name:
ARGX Stock Symbol:
NASDAQ Market:
2024-06-26 07:00:04 ET Douglas Tsao from H.C. Wainwright issued a price target of $490.00 for ARGX on 2024-06-26 06:09:00. The adjusted price target was set to $490.00. At the time of the announcement, ARGX was trading at $451.55. The overall price target consensus is at...
ARDA study data show potential for empasiprubart to drive functional improvement and reduced risk of relapse for multifocal motor neuropathy (MMN) patients ADHERE+ data show durability of functional improvements with VYVGART® Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) , w...
2024-06-24 16:00:10 ET Joon Lee from Truist Financial issued a price target of $480.00 for ARGX on 2024-06-24 14:06:00. The adjusted price target was set to $480.00. At the time of the announcement, ARGX was trading at $441.155. The overall price target consensus is at $...